ETF Holdings Breakdown of TNGX

Stock NameTango Therapeutics Inc
TickerTNGX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS87583X1090

News associated with TNGX

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Average Rating of “Buy” from Analysts
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has earned an average recommendation of “Buy” from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 12 month target price among analysts that have covered the stock in the last […] - 2025-05-09 06:12:43
Brokerages Set Tango Therapeutics, Inc. (NASDAQ:TNGX) PT at $12.33
Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) have been assigned an average recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the […] - 2025-04-17 05:08:48
American Century Companies Inc. Increases Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)
American Century Companies Inc. grew its position in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) by 12.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 110,448 shares of the company’s stock after purchasing an additional 12,162 shares during the quarter. American Century Companies Inc.’s holdings in Tango Therapeutics were worth $341,000 as […] - 2025-04-14 07:42:49
Schroder Investment Management Group Makes New Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX)
Schroder Investment Management Group bought a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 655,158 shares of the company’s stock, valued at approximately $2,031,000. Schroder Investment Management Group owned approximately 0.61% […] - 2025-04-07 08:11:04
Los Angeles Capital Management LLC Makes New $218,000 Investment in Tango Therapeutics, Inc. (NASDAQ:TNGX)
Los Angeles Capital Management LLC purchased a new stake in Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 70,452 shares of the company’s stock, valued at approximately $218,000. Los Angeles Capital Management […] - 2025-03-05 10:41:43
Analysts Set Tango Therapeutics, Inc. (NASDAQ:TNGX) PT at $12.33
Tango Therapeutics, Inc. (NASDAQ:TNGX – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued ratings on the stock in […] - 2025-02-26 06:22:50

TNGX institutional holdings

The following institutional investment holdings of TNGX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-02-27 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 50,867USD 110,890 -6.9%
2025-02-27 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 117,989USD 257,216 -6.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 52,230USD 57,453
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 52,230USD 57,453 -4.5%
2024-11-12 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,711USD 5,732
Total =275,027 USD 488,744
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.